Financhill
Sell
44

NONOF Quote, Financials, Valuation and Earnings

Last price:
$66.23
Seasonality move :
3.84%
Day range:
$66.90 - $71.44
52-week range:
$55.28 - $149.55
Dividend yield:
2.43%
P/E ratio:
20.78x
P/S ratio:
7.23x
P/B ratio:
15.13x
Volume:
69.8K
Avg. volume:
125.3K
1-year change:
-43.84%
Market cap:
$302.9B
Revenue:
$42.1B
EPS (TTM):
$3.28

Earnings Data

Next earnings date for NONOF
May 07
2025
Most recent earnings per share
$0.91
Beat by $0.91
(Feb 5/2025)
Consensus Estimate
--
(Feb 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NONOF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $11.9B -- -- -- --
05/07/2025 Q1 $11.8B -- -- -- --
02/05/2025 Q4 $11.5B $12.2B $0.91 -- --
11/06/2024 Q3 $10.5B $10.5B $0.90 -- --
08/07/2024 Q2 $10.1B $9.8B $0.65 -- --
05/02/2024 Q1 $9.1B $9.5B $0.83 -- --
12/31/2023 Q4 $8.9B $9.5B $0.71 -- --
09/30/2023 Q3 $8.1B $8.6B $0.73 -- --
08/10/2023 Q2 $8.2B $7.9B $0.63 -- --
05/04/2023 Q1 $7.7B $7.7B $0.63 -- --
02/02/2023 Q4 $6.9B $6.6B $0.41 -- --
11/02/2022 Q3 -- $6.2B $0.43 -- --
08/04/2022 Q2 -- $5.9B $0.42 -- --
05/12/2022 Q1 -- $6.3B $0.47 -- --
02/02/2022 Q4 -- $5.9B $0.37 -- --
11/03/2021 Q3 -- $5.6B $0.42 -- --
08/04/2021 Q2 -- $5.4B $0.43 -- --
05/05/2021 Q1 -- $5.5B $0.44 -- --
02/03/2021 Q4 -- $5.1B $0.32 -- --
10/30/2020 Q3 -- $4.9B $0.35 -- --
08/06/2020 Q2 -- $4.4B $0.33 -- --
05/06/2020 Q1 -- $5B $0.37 -- --
12/31/2019 Q4 -- $4.8B $0.27 -- --
09/30/2019 Q3 -- $4.5B $0.32 -- --
06/30/2019 Q2 -- $4.5B $0.30 -- --
03/31/2019 Q1 -- $4.5B $0.33 -- --
12/31/2018 Q4 -- $4.5B $0.27 -- --
09/30/2018 Q3 -- $4.3B $0.29 -- --
06/30/2018 Q2 -- $4.4B $0.34 -- --
03/31/2018 Q1 -- $4.4B $0.36 -- --
12/31/2017 Q4 -- $4.4B $0.27 -- --
09/30/2017 Q3 -- $4.2B $0.31 -- --
06/30/2017 Q2 -- $4.2B $0.30 -- --
03/31/2017 Q1 -- $4.1B $0.29 -- --
12/31/2016 Q4 -- $4.3B $0.25 -- --
09/30/2016 Q3 -- $4.1B $0.29 -- --
06/30/2016 Q2 -- $4.2B $0.30 -- --
03/31/2016 Q1 -- $4B $0.27 -- --
12/31/2015 Q4 -- $4.2B $0.24 -- --
09/30/2015 Q3 -- $4B $0.24 -- --
06/30/2015 Q2 -- $4B $0.24 -- --

Novo Nordisk AS Earnings Questions

  • How Much did Novo Nordisk AS Generate in Revenue Last Quarter?

    Novo Nordisk AS reported $12.2B worth of top line sales in its most recent quarter.

  • Did Novo Nordisk AS Beat Earnings Last Quarter?

    Novo Nordisk AS announced earnings per share of $0.91 which represents a beat of analyst forecast a -- per share.

  • Is Novo Nordisk AS Profitable?

    Novo Nordisk AS reported $10.4B that represents $2.33 per share over the last quarter.

  • What is the Analyst Consensus for Novo Nordisk AS EPS Next Year?

    Novo Nordisk AS's earnings are forecast to grow from $3.28 per share to $2.68 per share next year representing an increase of 18.5%.

  • When is Novo Nordisk AS's Earnings Date?

    Novo Nordisk AS's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Is RTX The Best Growth Stock?
Is RTX The Best Growth Stock?

Among the worldwide aerospace and defense markets, the US controls…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock